Pancreatic cancer risk and early-detection registry study
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study builds a database of people at higher risk for pancreatic cancer (or certain early warning findings) to help find better ways to detect the disease early. You may be asked to complete health questionnaires and possibly donate a blood/saliva/swab sample.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re being evaluated at a participating site for pancreatic cancer (PDAC) risk (or related screening).
- You have no prior pancreatic cancer for Cohorts 1–5, OR you have pancreatic cancer/high-grade pre-cancer findings for Cohorts 6a–6d.
- You may qualify if you have a strong family history of pancreatic cancer (for example, a close relative affected at an early age) or specific inherited gene changes.
- If you’re in Cohort 1–3, your age must match the study’s age thresholds for your risk pattern.
- If you’re in the cyst group, you have a pancreatic cystic condition and no known strong family history or high-risk gene change.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry (a way to track health over time) for people with a strong family history or certain inherited genetic risks for pancreatic cancer. It may help doctors learn how best to monitor and protect high-risk people, and to see who benefits most from follow-up.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
This study is a registry for people at high risk for pancreatic cancer. Researchers will collect information over time to learn more about how to detect and prevent the disease.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study looks at blood “markers” to find early signs or higher risk for pancreatic cancer. You may join if you have certain risk factors (like new diabetes, pancreatic cysts/pancreatitis, or a strong family history) and can come to Omaha for blood draws twice a year.
This is a “registry” study that collects health information from adults with pancreatic ductal adenocarcinoma before starting treatment. It may help researchers better understand the disease and how patients are managed in real life.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.